tiprankstipranks
Trending News
More News >
Xvivo Perfusion AB (XVIPF)
OTHER OTC:XVIPF
US Market

Xvivo Perfusion AB (XVIPF) Income Statement

Compare
10 Followers

Xvivo Perfusion AB Income Statement

Last quarter (Q4 2025), Xvivo Perfusion AB's total revenue was kr226.14M, a decrease of -0.62% from the same quarter last year. In Q4, Xvivo Perfusion AB's net income was kr31.65M. See Xvivo Perfusion AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 812.16Mkr 822.41Mkr 597.54Mkr 415.29Mkr 258.39M
Gross Profit
kr 533.50Mkr 616.41Mkr 445.11Mkr 296.96Mkr 188.28M
Operating Expenses
kr 440.48Mkr 528.06Mkr 440.92Mkr 292.50Mkr 207.02M
Depreciation and Amortization
kr 70.21Mkr 67.42Mkr 30.86Mkr 15.80Mkr 32.26M
EBITDA
kr 153.14Mkr 272.97Mkr 35.05Mkr 39.21Mkr 39.20M
Operating Income
kr 93.02Mkr 88.35Mkr 4.19Mkr 23.18Mkr 6.98M
Other Income/Expenses
kr -54.46Mkr 111.59Mkr 90.33Mkr -867.00Kkr -317.00K
Pretax Income
kr 38.56Mkr 199.95Mkr 94.52Mkr 22.31Mkr 6.67M
Net Income
kr 25.16Mkr 172.18Mkr 91.82Mkr 18.43Mkr 8.15M
Per Share Metrics
Basic EPS
kr 0.80kr 5.47kr 3.07kr 0.62kr 0.28
Diluted EPS
kr 0.80kr 5.44kr 3.07kr 0.62kr 0.28
Weighted Average Shares Outstanding
31.50M 31.50M 29.94M 29.53M 28.85M
Weighted Average Shares Outstanding (Diluted)
31.56M 31.67M 29.94M 29.53M 28.94M
Currency in SEK

Xvivo Perfusion AB Earnings and Revenue History